Provided by Tiger Fintech (Singapore) Pte. Ltd.

TG Therapeutics

45.37
-0.1400-0.31%
Post-market: 45.27-0.1000-0.22%19:33 EDT
Volume:2.55M
Turnover:116.01M
Market Cap:7.20B
PE:302.47
High:46.48
Open:45.49
Low:44.05
Close:45.51
Loading ...
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2024

Major Issues Report

Form 8-K - Current report